Tumor immune microenvironment in pituitary neuroendocrine tumors (PitNETs): increased M2 macrophage infiltration and PD-L1 expression in PIT1-lineage subset
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tumor immune microenvironment in pituitary neuroendocrine tumors (PitNETs): increased M2 macrophage infiltration and PD-L1 expression in PIT1-lineage subset
Authors
Keywords
-
Journal
JOURNAL OF NEURO-ONCOLOGY
Volume 163, Issue 3, Pages 663-674
Publisher
Springer Science and Business Media LLC
Online
2023-07-07
DOI
10.1007/s11060-023-04382-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Single-cell sequencing of PIT1-positive pituitary adenoma highlights the pro-tumour microenvironment mediated by IFN-γ-induced tumour-associated fibroblasts remodelling
- (2023) Liang Lyu et al. BRITISH JOURNAL OF CANCER
- Predictive Biomarkers for Immune-Related Endocrinopathies following Immune Checkpoint Inhibitors Treatment
- (2023) Almog Shalit et al. Cancers
- Diagnosis and Management of Pituitary Adenomas
- (2023) Nicholas A. Tritos et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Aggressive Pituitary Tumors and Pituitary Carcinomas: From Pathology to Treatment
- (2023) Pia Burman et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Tumour microenvironment and pituitary tumour behaviour
- (2023) P. Marques et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- The microenvironment of pituitary adenomas: biological, clinical and therapeutical implications
- (2022) Pedro Marques et al. Pituitary
- Overview of the 2022 WHO Classification of Pituitary Tumors
- (2022) Sylvia L. Asa et al. ENDOCRINE PATHOLOGY
- Clinical Biology of the Pituitary Adenoma
- (2022) Shlomo Melmed et al. ENDOCRINE REVIEWS
- Immunotherapy in aggressive pituitary tumors and carcinomas: a systematic review
- (2022) Mirela Diana Ilie et al. ENDOCRINE-RELATED CANCER
- The complex role of tumor-infiltrating macrophages
- (2022) Anthos Christofides et al. NATURE IMMUNOLOGY
- Biological and Therapeutic Implications of the Tumor Microenvironment in Pituitary Adenomas
- (2022) Mirela-Diana ILIE et al. ENDOCRINE REVIEWS
- Real-life efficacy and predictors of response to immunotherapy in pituitary tumors: a cohort study
- (2022) Mirela Diana Ilie et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Immune cellular components and signaling pathways in the tumor microenvironment
- (2022) Sasitorn Yenyuwadee et al. SEMINARS IN CANCER BIOLOGY
- Macrophage colony‐stimulating factor potentially induces recruitment and maturation of macrophages in recurrent pituitary neuroendocrine tumors
- (2022) Hiroaki Matsuzaki et al. MICROBIOLOGY AND IMMUNOLOGY
- Immune profiling of pituitary tumors reveals variations in immune infiltration and checkpoint molecule expression
- (2021) Yu Mei et al. Pituitary
- PD-L1 Is Preferentially Expressed in PIT-1 Positive Pituitary Neuroendocrine Tumours
- (2021) John Turchini et al. ENDOCRINE PATHOLOGY
- Beyond immune checkpoint blockade: emerging immunological strategies
- (2021) Shawn P. Kubli et al. NATURE REVIEWS DRUG DISCOVERY
- POU1F1 transcription factor induces metabolic reprogramming and breast cancer progression via LDHA regulation
- (2021) Anxo Martínez-Ordoñez et al. ONCOGENE
- Endocrine toxicities of immune checkpoint inhibitors
- (2021) Jordan J. Wright et al. Nature Reviews Endocrinology
- Predictive biomarkers for response to immune checkpoint inhibition
- (2021) Benjamin Shum et al. SEMINARS IN CANCER BIOLOGY
- HMGA1B/2 transcriptionally activated-POU1F1 facilitates gastric carcinoma metastasis via CXCL12/CXCR4 axis-mediated macrophage polarization
- (2021) Cheng Tang et al. Cell Death & Disease
- Research advances on the immune research and prospect of immunotherapy in pituitary adenomas
- (2021) Ding Nie et al. World Journal of Surgical Oncology
- Tumor-Associated Macrophages: New Horizons for Pituitary Adenoma Researches
- (2021) Changxi Han et al. Frontiers in Endocrinology
- Expression of programmed death-ligand 1 (PD-L1) in human pituitary neuroendocrine tumor
- (2020) Valentine Suteau et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- In silico analysis of the immunological landscape of pituitary adenomas
- (2020) Jacky T. Yeung et al. JOURNAL OF NEURO-ONCOLOGY
- Immunotherapy and potential molecular targets for the treatment of pituitary adenomas resistant to standard therapy: a critical review of potential therapeutic targets and current developments
- (2020) Tamara Maghathe et al. Journal of Neurosurgical Sciences
- Immune Landscape of Pituitary Neuroendocrine Tumours Reveals Association between Macrophages and Gonadotroph-Tumour Invasion
- (2020) Moitza Principe et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Stratifying nonfunctional pituitary adenomas into two groups distinguished by macrophage subtypes
- (2019) Garima Yagnik et al. Oncotarget
- Analysis of Tumor Angiogenesis and Immune Microenvironment in Non-Functional Pituitary Endocrine Tumors
- (2019) Mizuto Sato et al. Journal of Clinical Medicine
- Targeting PD-L1 initiates effective anti-tumor immunity in a murine model of Cushing's Disease
- (2019) Hanna R Kemeny et al. CLINICAL CANCER RESEARCH
- Chemokines modulate the tumour microenvironment in pituitary neuroendocrine tumours
- (2019) Pedro Marques et al. Acta Neuropathologica Communications
- The 2017 WHO classification of pituitary adenoma: overview and comments
- (2018) Naoko Inoshita et al. Brain Tumor Pathology
- The Epigenomic Landscape of Pituitary Adenomas Reveals Specific Alterations and Differentiates Among Acromegaly, Cushing's Disease and Endocrine-Inactive Subtypes
- (2018) Matthew P. Salomon et al. CLINICAL CANCER RESEARCH
- Regulation and Function of the PD-L1 Checkpoint
- (2018) Chong Sun et al. IMMUNITY
- The expression profile of PD-L1 and CD8+ lymphocyte in pituitary adenomas indicating for immunotherapy
- (2018) Peng-fei Wang et al. JOURNAL OF NEURO-ONCOLOGY
- Breast cancer metastasis to liver and lung is facilitated by Pit-1-CXCL12-CXCR4 axis
- (2018) Anxo Martinez-Ordoñez et al. ONCOGENE
- Biomarkers for predicting efficacy of PD-1/PD-L1 inhibitors
- (2018) Ming Yi et al. Molecular Cancer
- Detection of programmed death ligand 1 protein and CD8+ lymphocyte infiltration in plurihormonal pituitary adenomas
- (2017) Pengfei Wang et al. MEDICINE
- Increased expression of programmed death ligand 1 (PD-L1) in human pituitary tumors
- (2016) Yu Mei et al. Oncotarget
- Immune Cell Infiltrates in Pituitary Adenomas: More Macrophages in Larger Adenomas and More T Cells in Growth Hormone Adenomas
- (2015) Jian-Qiang Lu et al. ENDOCRINE PATHOLOGY
- Invasion of the cavernous sinus space in pituitary adenomas: endoscopic verification and its correlation with an MRI-based classification
- (2015) Alexander S. G. Micko et al. JOURNAL OF NEUROSURGERY
- Robust enumeration of cell subsets from tissue expression profiles
- (2015) Aaron M Newman et al. NATURE METHODS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started